Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2001080713) METHODS FOR NON-PERMANENT OCCLUSION OF A UTERINE ARTERY
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2001/080713 International Application No.: PCT/US2001/010803
Publication Date: 01.11.2001 International Filing Date: 16.04.2001
Chapter 2 Demand Filed: 09.11.2001
IPC:
A61B 17/00 (2006.01) ,A61B 17/12 (2006.01) ,A61B 17/42 (2006.01) ,A61K 31/045 (2006.01) ,A61K 31/10 (2006.01) ,A61K 31/734 (2006.01) ,A61K 45/06 (2006.01) ,A61L 24/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
B
DIAGNOSIS; SURGERY; IDENTIFICATION
17
Surgical instruments, devices or methods, e.g. tourniquets
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
B
DIAGNOSIS; SURGERY; IDENTIFICATION
17
Surgical instruments, devices or methods, e.g. tourniquets
12
for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
B
DIAGNOSIS; SURGERY; IDENTIFICATION
17
Surgical instruments, devices or methods, e.g. tourniquets
42
Gynaecological or obstetrical instruments or methods
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
045
Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
095
Sulfur, selenium or tellurium compounds, e.g. thiols
10
Sulfides; Sulfoxides; Sulfones
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
70
Carbohydrates; Sugars; Derivatives thereof
715
Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
734
Alginic acid
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45
Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
06
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
L
METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
24
Surgical adhesives or cements; Adhesives for colostomy devices
Applicants:
BURBANK, Fred [US/US]; US (UsOnly)
ALTIERI, Greig, E. [US/US]; US (UsOnly)
JONES, Michael, L. [US/US]; US (UsOnly)
HYSTERX, INC. [US/US]; 32236-E Paseo Adelanto San Juan Capistrano, CA 92675, US (AllExceptUS)
Inventors:
BURBANK, Fred; US
ALTIERI, Greig, E.; US
JONES, Michael, L.; US
Agent:
KREBS, Robert, E.; Burns, Doane, Swecker & Mathis, LLP P.O BOX 1404 Alexandria, VA 22313, US
Priority Data:
09/556,93421.04.2000US
Title (EN) METHODS FOR NON-PERMANENT OCCLUSION OF A UTERINE ARTERY
(FR) PROCEDES D'OCCLUSION NON PERMANENTE D'UNE ARTERE UTERINE
Abstract:
(EN) Non-permanent occlusion of the uterine arteries (22) is sufficient to cause the demise of uterine myomata without unnecessarily exposing other tissues and anatomical structures to hypoxia attendant to prior permanent occlusion techniques. A therapeutically effective transient time of occlusion of a uterine artery (22) to treat uterine fibroid tumors (12) is from 1 hours to 24 hours, and preferably is at least about 4 hours. A therapeutically effective temporary time of occlusion of a uterine artery (22) to treat uterine fibroid tumors (12) is from 1 day (24 hours) to 7 days (168 hours), and preferably is about 4 days (96 hours).
(FR) Une occlusion non permanente des artères utérines est suffisante pour traiter un myome utérin sans qu'il soit nécessaire d'exposer d'autres tissus et d'autres structures anatomiques à une hypoxie, comme c'était le cas avec les techniques d'occlusion permanente mises en oeuvre jusqu'à maintenant. Une période transitoire, thérapeutiquement efficace, d'occlusion d'une artère utérine pour traiter des fibromes peut aller d'1 heure à 24 heures et sera, de préférence, d'au moins environ 4 heures. Une période temporaire, thérapeutiquement efficace, d'occlusion d'une artère utérine pour traiter des fibromes peut aller de 1 jour (24 heures) à 7 jours (168 heures) et sera, de préférence, d'environ 4 jours (96 heures).
front page image
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)